{
    "2018-02-12": [
        [
            {
                "time": "2018-01-02",
                "original_text": "Bristol-Myers Squibb’s 4Q17 Earnings Performance",
                "features": {
                    "keywords": [
                        "Bristol-Myers",
                        "Squibb",
                        "4Q17",
                        "Earnings",
                        "Performance"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Is AbbVie or Vertex Pharmaceuticals the Better Buy Now?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Vertex",
                        "Pharmaceuticals",
                        "Better",
                        "Buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Johnson & Johnson -- JNJ",
                "features": {
                    "keywords": [
                        "Investor",
                        "Alert",
                        "Levi",
                        "Korsinsky",
                        "Securities",
                        "Fraud",
                        "Johnson",
                        "Johnson"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Health Care Select Sector SPDR Fund Experiences Big Outflow",
                "features": {
                    "keywords": [
                        "Health",
                        "Care",
                        "Select",
                        "Sector",
                        "SPDR",
                        "Fund",
                        "Outflow"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "What Analysts Recommend for Pfizer after 4Q17",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommend",
                        "Pfizer",
                        "4Q17"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "New drug promises to kill flu virus in a day",
                "features": {
                    "keywords": [
                        "New",
                        "drug",
                        "flu",
                        "virus"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Cardinal Health a Top Ranked SAFE Dividend Stock With 2.8% Yield (CAH)",
                "features": {
                    "keywords": [
                        "Cardinal",
                        "Health",
                        "SAFE",
                        "Dividend",
                        "Stock",
                        "Yield"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "What’s Pfizer’s Valuation after 4Q17 Earnings?",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Valuation",
                        "4Q17",
                        "Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Amgen’s Nephrology Drugs: Aranesp, Epogen, Sensipar in 4Q17",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Nephrology",
                        "Drugs",
                        "Aranesp",
                        "Epogen",
                        "Sensipar",
                        "4Q17"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "The Tax Law Is About to Make Analyzing Earnings Trickier",
                "features": {
                    "keywords": [
                        "Tax",
                        "Law",
                        "Analyzing",
                        "Earnings"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-01-02",
                "original_text": "Experimental Drug Promises to Kill the Flu Virus in a Day",
                "features": {
                    "keywords": [
                        "Experimental",
                        "Drug",
                        "Flu",
                        "Virus"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}